Multiple vertebral fractures following withdrawal of denosumab: 3 case reports

    This is a preview of subscription content, log in to check access.


    1. Dickens L, et al. Oral vs intravenous bisphosphonates for preventing bone loss after denosumab discontinuation. Journal of Bone and Mineral Research 34 (Suppl. 1): 182-183 (plus poster) abstr. LB SAT-1069, Dec 2019 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Denosumab. Reactions Weekly 1810, 87 (2020).

    Download citation